Search
for
Sort by
Research 30 of 247
- A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone–Collagen Binding Domain (PTH–CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
- Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- 1108 Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata
- Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain
- Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner
- Treatment of Alopecia Areata in Mice by Stimulating the Hair Follicles Using Parathyroid Hormone Agonists Linked to a Collagen Binding Domain
- Treatment for chemotherapy‐induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth?
- Chemotherapy‐induced alopecia – the urgent need for treatment options
- Emerging treatments in alopecia
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
- Present Chemotherapy Induced Alopecia and Research in Future
- New drugs under investigation for the treatment of alopecias
- Structures of three polycystic kidney disease-like domains from<i>Clostridium histolyticum</i>collagenases ColG and ColH
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia
- Investigation of Transcriptional Gene Profiling in Normal Murine Hair Follicular Substructures Using Next-Generation Sequencing to Provide Potential Insights into Skin Disease
- Wnt Signaling Across Adult Skin Mini-Organs: Interfollicular Epidermis, Hair Follicle, and Nail—Implications for Disease and Regeneration
- Hair & Cutaneous Development
- Parathyroid Hormone Hormone-Related Protein and the PTH Receptor Regulate Angiogenesis of the Skin
- Mouse models with a disrupted PTHrP gene or a disrupted PTH gene (PTH−/− mice)
- Rickets with alopecia: An inborn error of vitaminD metabolism
- Vitamin D Receptor: Key Roles in Bone Mineral Pathophysiology, Molecular Mechanism of Action, and Novel Nutritional Ligands
- Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata
- The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3
- A Topical Parathyroid Hormone/Parathyroid Hormone-Related Peptide Receptor Antagonist Stimulates Hair Growth in Mice